Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

There is a necessity to better characterize uveal melanoma (UM) tumors according to their metastasis potential at an early stage. In this study we report the identification of potential biomarkers by a combination of proteomics-related approaches: the characterization of UM cell secretomes, the analysis of UM autoantibodies, and the differential depleted serum proteome analysis. We describe a possible role of cathepsin D, syntenin, and gp100 in UM as potential biomarkers.

Original publication




Journal article


J Proteome Res

Publication Date





2802 - 2811


Antibodies, Neoplasm, Autoantibodies, Biomarkers, Tumor, Cathepsin D, Cell Line, Tumor, Humans, Melanoma, Membrane Glycoproteins, Proteome, Uveal Neoplasms, gp100 Melanoma Antigen